Literature DB >> 11513617

Sequence requirements of the ATP-binding site within the C-terminal nucleotide-binding domain of mouse P-glycoprotein: structure-activity relationships for flavonoid binding.

H de Wet1, D B McIntosh, G Conseil, H Baubichon-Cortay, T Krell, J M Jault, J B Daskiewicz, D Barron, A Di Pietro.   

Abstract

Sequence requirements of the ATP-binding site within the C-terminal nucleotide-binding domain (NBD2) of mouse P-glycoprotein were investigated by using two recombinantly expressed soluble proteins of different lengths and photoactive ATP analogues, 8-azidoadenosine triphosphate (8N(3)-ATP) and 2',3',4'-O-(2,4,6-trinitrophenyl)-8-azidoadenosine triphosphate (TNP-8N(3)-ATP). The two proteins, Thr(1044)-Thr(1224) (NBD2(short)) and Lys(1025)-Ser(1276) (NBD2(long)), both incorporated the four consensus sequences of ABC (ATP-binding cassette) transporters, Walker A and B motifs, the Q-loop, and the ABC signature, while differing in N-terminal and C-terminal extensions. Radioactive photolabeling of both proteins was characterized by hyperbolic dependence on nucleotide concentration and high-affinity binding with K(0.5)(8N(3)-ATP) = 36-37 microM and K(0.5)(TNP-8N(3)-ATP) = 0.8-2.6 microM and was maximal at acidic pH. Photolabeling was strongly inhibited by TNP-ATP (K(D) = 0.1-5 microM) and ATP (K(D) = 0.5-2.7 mM). Since flavonoids display bifunctional interactions at the ATP-binding site and a vicinal steroid-interacting hydrophobic sequence [Conseil, G., Baubichon-Cortay, H., Dayan, G., Jault, J.-M., Barron, D., and Di Pietro, A. (1998) Proc. Natl. Acad. Sci. U.S.A. 95, 9831-9836], a series of 30 flavonoids from different classes were investigated for structure-activity relationships toward binding to the ATP site, monitored by protection against photolabeling. The 3-OH and aromaticity of conjugated rings A and C appeared important, whereas opening of ring C abolished the binding in all but one case. It can be concluded that the benzopyrone portion of the flavonoids binds at the adenyl site and the phenyl ring B at the ribosyl site. The Walker A and B motifs, intervening sequences, and small segments on both sides are sufficient to constitute the ATP site.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11513617     DOI: 10.1021/bi010657c

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Definition of the domain boundaries is critical to the expression of the nucleotide-binding domains of P-glycoprotein.

Authors:  Ian D Kerr; Georgina Berridge; Kenneth J Linton; Christopher F Higgins; Richard Callaghan
Journal:  Eur Biophys J       Date:  2003-06-26       Impact factor: 1.733

2.  Glutamine residues in Q-loops of multidrug resistance protein MRP1 contribute to ATP binding via interaction with metal cofactor.

Authors:  Runying Yang; Yue-xian Hou; Chase A Campbell; Kanagaraj Palaniyandi; Qing Zhao; Andrew J Bordner; Xiu-bao Chang
Journal:  Biochim Biophys Acta       Date:  2011-02-26

3.  Flavonoid dimers as bivalent modulators for pentamidine and sodium stiboglucanate resistance in leishmania.

Authors:  Iris L K Wong; Kin-Fai Chan; Brendan A Burkett; Yunzhe Zhao; Yi Chai; Hongzhe Sun; Tak Hang Chan; Larry M C Chow
Journal:  Antimicrob Agents Chemother       Date:  2006-12-28       Impact factor: 5.191

4.  Effects of putative catalytic base mutation E211Q on ABCG2-mediated methotrexate transport.

Authors:  Yue-xian Hou; Chang-Zhong Li; Kanagaraj Palaniyandi; Paul M Magtibay; Laszlo Homolya; Balazs Sarkadi; Xiu-bao Chang
Journal:  Biochemistry       Date:  2009-09-29       Impact factor: 3.162

5.  Identification of novel specific and general inhibitors of the three major human ATP-binding cassette transporters P-gp, BCRP and MRP2 among registered drugs.

Authors:  Pär Matsson; Jenny M Pedersen; Ulf Norinder; Christel A S Bergström; Per Artursson
Journal:  Pharm Res       Date:  2009-05-07       Impact factor: 4.200

6.  Flavonoids from each of the six structural groups reactivate BRM, a possible cofactor for the anticancer effects of flavonoids.

Authors:  Bhaskar Kahali; Stefanie B Marquez; Kenneth W Thompson; Jinlong Yu; Sarah J B Gramling; Li Lu; Aaron Aponick; David Reisman
Journal:  Carcinogenesis       Date:  2014-05-29       Impact factor: 4.944

7.  A plausible explanation for enhanced bioavailability of P-gp substrates in presence of piperine: simulation for next generation of P-gp inhibitors.

Authors:  Durg Vijay Singh; Madan M Godbole; Krishna Misra
Journal:  J Mol Model       Date:  2012-08-04       Impact factor: 1.810

8.  Secondary Metabolites from Plants Inhibiting ABC Transporters and Reversing Resistance of Cancer Cells and Microbes to Cytotoxic and Antimicrobial Agents.

Authors:  Michael Wink; Mohamed L Ashour; Mahmoud Zaki El-Readi
Journal:  Front Microbiol       Date:  2012-04-23       Impact factor: 5.640

Review 9.  Flavonoids Alleviate Peripheral Neuropathy Induced by Anticancer Drugs.

Authors:  Manaal Siddiqui; Basma Abdellatif; Kevin Zhai; Alena Liskova; Peter Kubatka; Dietrich Büsselberg
Journal:  Cancers (Basel)       Date:  2021-03-29       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.